國立高雄大學圖資館 |

登入

回首頁

Infectious complications in biologic and targeted therapies

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Infectious complications in biologic and targeted therapiesedited by Carlos Cervera, Jose Maria Aguado.
其他作者:	Cervera, Carlos.
出版者:	Cham :Springer International Publishing :2022.
面頁冊數:	x, 473 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	InfectionPrevention.
電子資源:	https://doi.org/10.1007/978-3-031-11363-5
ISBN:	9783031113635$q(electronic bk.)

Infectious complications in biologic and targeted therapies
Infectious complications in biologic and targeted therapies[electronic resource] /edited by Carlos Cervera, Jose Maria Aguado. - Cham :Springer International Publishing :2022. - x, 473 p. :ill., digital ;24 cm.

This book aims to approach the epidemiology, diagnosis and management of infectious complications related to the use of biologic and targeted therapies. The first part is a general overview on the epidemiology and prevention of infections with the use of these agents. Timelines, pre-treatment evaluation, use of vaccines and travel counseling. In the second part, we will analyze the specific risk of infections associated with the use of the most important agents. The third part approach the problem on a syndromic point of view. For example, how to evaluate pulmonary infiltrates in a patient receiving biologic agents. This part III includes the most difficult and conflicting syndromes that clinicians may face when evaluating these patients. This book is intended not only for infectious diseases specialists, but also for different medical specialties prescribing biologic and targeted therapies.

ISBN: 9783031113635$q(electronic bk.)

Standard No.: 10.1007/978-3-031-11363-5doiSubjects--Topical Terms:

606739
Infection
--Prevention.

LC Class. No.: RC111

Dewey Class. No.: 616.9

Infectious complications in biologic and targeted therapies
LDR:01862nmm a2200313 a 4500 001 633596
003 DE-He213
005 20221118130254.0
006 m d
007 cr nn 008maaau
008 230511s2022 sz s 0 eng d
020 $a 9783031113635$q(electronic bk.)
020 $a 9783031113628$q(paper)
024 7 $a 10.1007/978-3-031-11363-5 $2 doi
035 $a 978-3-031-11363-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC111
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616.9 $2 23
090 $a RC111 $b .I43 2022
245 0 0 $a Infectious complications in biologic and targeted therapies $h [electronic resource] / $c edited by Carlos Cervera, Jose Maria Aguado.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a x, 473 p. : $b ill., digital ; $c 24 cm.
520 $a This book aims to approach the epidemiology, diagnosis and management of infectious complications related to the use of biologic and targeted therapies. The first part is a general overview on the epidemiology and prevention of infections with the use of these agents. Timelines, pre-treatment evaluation, use of vaccines and travel counseling. In the second part, we will analyze the specific risk of infections associated with the use of the most important agents. The third part approach the problem on a syndromic point of view. For example, how to evaluate pulmonary infiltrates in a patient receiving biologic agents. This part III includes the most difficult and conflicting syndromes that clinicians may face when evaluating these patients. This book is intended not only for infectious diseases specialists, but also for different medical specialties prescribing biologic and targeted therapies.
650 0 $a Infection $x Prevention. $3 606739
650 0 $a Infection $x Treatment. $3 467105
650 0 $a Therapeutics $x Complications. $3 731852
650 0 $a Drug targeting. $3 194481
700 1 $a Cervera, Carlos. $3 939581
700 1 $a Aguado, Jose Maria. $3 939582
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-11363-5
950 $a Medicine (SpringerNature-11650)